scholarly journals Virtual Screening and Optimization Yield Low-Nanomolar Inhibitors of the Tautomerase Activity of Plasmodium falciparum Macrophage Migration Inhibitory Factor

2012 ◽  
Vol 55 (22) ◽  
pp. 10148-10159 ◽  
Author(s):  
Markus K. Dahlgren ◽  
Alvaro Baeza Garcia ◽  
Alissa A. Hare ◽  
Julian Tirado-Rives ◽  
Lin Leng ◽  
...  
2009 ◽  
Vol 52 (2) ◽  
pp. 416-424 ◽  
Author(s):  
Zoe Cournia ◽  
Lin Leng ◽  
Sunilkumar Gandavadi ◽  
Xin Du ◽  
Richard Bucala ◽  
...  

2009 ◽  
Vol 18 (12) ◽  
pp. 2578-2591 ◽  
Author(s):  
Sarah E. Dobson ◽  
Kevin D. Augustijn ◽  
James A. Brannigan ◽  
Claudia Schnick ◽  
Chris J. Janse ◽  
...  

2005 ◽  
Vol 73 (6) ◽  
pp. 3287-3293 ◽  
Author(s):  
Sujittra Chaisavaneeyakorn ◽  
Naomi Lucchi ◽  
Carlos Abramowsky ◽  
Caroline Othoro ◽  
Sansanee C. Chaiyaroj ◽  
...  

ABSTRACT Previously, we have shown that macrophage migration inhibitory factor (MIF) was highly elevated in the placental intervillous blood (IVB) of Plasmodium falciparum-infected women. Here, we compared the expression of MIF in placental tissues obtained from P. falciparum-infected and -uninfected women. Immunoperoxidase staining showed a consistent pattern of MIF expression in syncytiotrophoblasts, extravillous trophoblasts, IVB mononuclear cells, and amniotic epithelial cells, irrespective of their malaria infection status. Cytotrophoblast, villous stroma, and Hofbauer cells showed focal staining. Only amniotic epithelial and IVB mononuclear cells from P. falciparum-infected placentas exhibited significantly higher level of MIF expression than uninfected placentas. Stimulation of syncytilized human trophoblast BeWo cells with P. falciparum-infected erythrocytes that were selected to bind these cells resulted in significant increases in MIF secretion, whereas control erythrocytes, lipopolysaccharides, and synthetic β-hematin had minimal effect. These findings suggest that placental malaria modulates MIF expression in different placental compartments.


2014 ◽  
Vol 19 (7) ◽  
pp. 1116-1123 ◽  
Author(s):  
Tsung-Lin Tsai ◽  
Thy-Hou Lin

Macrophage migration inhibitory factor (MIF) is an autocrine- and paracrine-acting cytokine that is involved in several inflammatory, autoimmune, infectious, and oncogenic diseases. Clinical data have shown that inhibition of MIF, especially its tautomerase activity, with small compounds has been beneficial in some disease models. A virtual screening (VS) experiment is conducted for searching some active compounds to inhibit the tautomerase activity of MIF from the ZINC database. By using an x-ray–determined structure OXIM-11 as the query and an in-house developed two-dimensional scaffold comparing method designated as Sfilter, we have screened out some 1500 compounds for ranking by our previously published docking method ADDock. After further ranking by ADDock on 119 compounds screened, we have decided to choose 17 of them for measuring their inhibitory activity IC50 against the MIF tautomerase experimentally. The IC50’s are measured using both human monocytic THP-1 cell lysate and purified recombinant human MIF protein. We have found that the IC50’s measured for three searched compounds (namely, ZINC02693801, ZINC00141102, and ZINC12368346) are better than that determined for ISO-1, a known MIF tautomerase inhibitor and standard used throughout our VS experiment. Moreover, the scaffolds of most of our active compounds searched are also quite different from those searched and published by others previously.


Sign in / Sign up

Export Citation Format

Share Document